| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0007 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.18 | 0.0007 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.4 | 0.0009 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |